Internal Server Error

About Louisiana Fund

Louisiana Fund is a venture capital firm founded in 2004. It is primarily based out of Baton Rouge, United States. As of Jun 2020, Louisiana Fund has invested in 17 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and HealthTech. Most recently it participated in the $***** Seed round of Omnidek Overall, Louisiana Fund portfolio has seen 2 acquisitions, namely Mezzo Technologies and Primorigen. A lot of funds co-invest with Louisiana Fund, with names like Atlanta Technology Angels sharing a substantial percentage of its portfolio. Louisiana Fund has team of 2 people including 2 partners.
Key Metrics
Team Members
Portfolio Count
Portfolio Locations
Rounds of Entry
Series A & Seed
Portfolio Acquisitions

Louisiana Fund's List of Top Investments

Louisiana Fund has a portfolio of 17 companies. Their most notable investments are in Omnidek and Esperance Pharmaceuticals.Their portfolio spans across United States and Germany. They have invested in Life Sciences, Enterprise Applications, HealthTech and 6 other sectors, across stages such as Series A, Seed stages. Here is the list of top investments by Louisiana Fund:
Cure4you is an online personal health management platform. Allows users to manage their personal health records electronically and provides a channel to share the documents with their doctors and have a video consultation with them. It allows users to keep their health records electronically by allowing users to create an account having all their health details and upload health-related documents. Also, lets patients log their home measurements of blood pressure, cholesterol, activity, and sleep levels and also stores the blood test results from your doctor. Also, provides a health card having a QR code of the user's profile. The PHR service is direct-to-patients while provides patient engagement solutions to the hospitals and clinics.

Key facts about Qure4u

Automating critical infrastructure management for enhanced reliability and efficiency. The company provides solutions for broadband providers and utilities, focusing on predictive analytics and maintenance automation. Their platform-as-a-service solution offers critical infrastructure management software and systems designed to predict failures and improve operational efficiency. A key feature is adaptive charging, which extends battery life. The company's solutions leverage a vast database of operational data to streamline maintenance and free up technicians. They offer hardware, software, and predictive analytics to monitor critical infrastructure. The company's solutions ensure internet reliability through active battery management and smart power systems. They provide state-of-health readings through their platform. The company is a B2B tech company offering a SaaS platform.

Key facts about Servato

Aortic valve repair solutions: simplifying, standardizing, and restoring valve function. They specialize in aortic annuloplasty technologies designed to resize, reshape, and stabilize the aortic valve. Their devices address aortic valve dilatation and restore normal coaptation geometry. They offer a comprehensive solution for various aortic valve conditions, including isolated aortic insufficiency, aneurysms, dissections, and bicuspid aortic valves. They provide surgeon training, case review resources, and a video library. Their technologies aim to simplify valve-sparing root replacement by stabilizing the annulus without root mobilization. They focus on advancing aortic valve repair techniques through innovation and education.

Key facts about BioStable

Developer of medical devices for gynecological procedures. Its first product to market, a cervical retraction device that uses gentle suction to engage and manipulate the cervix for a variety of gynecological procedures. Other products include an intrauterine device (IUD) inserter that aims at simplifying the insertion procedure and reducing the adverse events inherent in current insertion techniques. It claims to have received support grants from the Saving Lives at Birth consortium of the Gates Foundation, USAID, and others.

Key facts about Bioceptive

Developer of therapeutics for smoking cessation and other addictions. The company is developing a novel addiction treatment (EMB-001) that targets specific and complementary brain functions that drive the craving and relapse associated with these disorders, an approach based on breakthrough discoveries of the scientific founder. EMB-001 is a combination therapy of a cortisol synthesis inhibitor metyrapone and the benzodiazepine oxazepam.

Key facts about Embera Neuro

Louisiana Fund's Investments by Stage

Louisiana Fund has made 5 investments in Series A stage with an average round size of $3.38M and 1 investment in Seed stage.
Here are Louisiana Fund's investments by stage:
Stage of entry
No. of Investments
Series A
5
Seed
1
Breakdown of Louisiana Fund's investments by stage of entrySeries A (5)Seed (1)
Note: We have considered here, only first round of investments

Louisiana Fund's Investments by Sector

Louisiana Fund has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, Consumer, Energy Tech and HealthTech. Notably, it has invested in 14 Enterprise (B2B) companies, 14 Tech companies, 5 Software companies and at least 3 companies focusing on Saas.
Here are Louisiana Fund's investments by sector:
Sector
No. of Investments
Life Sciences
3
Enterprise Applications
2
Consumer
1
Energy Tech
1
HealthTech
1
Others
2
Breakdown of Louisiana Fund's investments by sectorsLife Sciences (3)Enterprise Applic... (2)
Note: We have considered here, only first round of investments

Louisiana Fund's Investments by Geography

Louisiana Fund has made most investments in United States (6).

Louisiana Fund's recent investments

Louisiana Fund has not made any investment in 2026 so far.
Here are the most recent investments by Louisiana Fund:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Jun 15, 2020
United States
Seed
8824
Jun 21, 2018
United States
Series A
5973
Jan 06, 2017
United States
Seed
9104
-
Aug 31, 2015
United States
Series A
3732
  [+2]
Aug 15, 2011
United States
Series A
2809
-

Acquired companies in Louisiana Fund's Portfolio

2 companies from Louisiana Fund's portfolio have been acquired. The most recent acquisition was Mezzo Technologies in Jul 2022 by Arcline for $*****.
Here are Louisiana Fund's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Jul 19, 2022
-
-
3803
Aug 06, 2019
Oct 21, 2006
Series A
3930

Team profile of Louisiana Fund

Louisiana Fund has a team of 2 members including 2 Partners located in United States. Louisiana Fund's team does not sit on the board of any company as of now.

Co-investors of Louisiana Fund

Over the past 20 years, 18 investors have co-invested in Louisiana Fund's portfolio companies. This includes only funds.

  • Top Co-investors of Louisiana Fund: 6 investors entered a company along with Louisiana Fund. These include investors like Atlanta Technology Angels (1 company).
  • Invested after Louisiana Fund: A total of 12 investors have invested in Louisiana Fund's portfolio after their investments. Top Investors include Innovation Catalyst (2 companies), Volition Capital (1 company) and United Communications (1 company).

Recent News related to Louisiana Fund

View all news related to Louisiana Fund

FAQs about Louisiana Fund

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford